Quality of care for patients with inflammatory bowel disease in East China

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

298

HTML

1914

Tables (1-4)

193

Sum=2405

Jan 28, 2008 (publication date) through Nov 12, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jan 28, 2008; 14(4): 612-616
Published online Jan 28, 2008. doi: 10.3748/wjg.14.612

Table 3 Suboptimal dose used in treatment of CD and UC

Clinical parameters	Proportion (%)
Suboptimal dose of aminosalicylate
Crohn's disease	27/68 (39.7)
Ulcerative colitis	0/106 (0.00)
Failure to use topical therapy	26/57 (45.6)
Failure to use corticosteroid	10/36 (27.8)
Failure to use immunomodulatory agents	41/51 (80.4)
Suboptimal dose of AZA	4/7 (57.1)

Citation: Zhu Q, Cao Q, Si JM. Quality of care for patients with inflammatory bowel disease in East China. World J Gastroenterol 2008; 14(4): 612-616
URL: https://www.wjgnet.com/1007-9327/full/v14/i4/612.htm
DOI: https://dx.doi.org/10.3748/wjg.14.612